Risk-adapted treatment reduced chemotherapy exposure for clinical stage I pediatric testicular cancer

BACKGROUND: Different from adult clinical stage I (CS1) testicular cancer, surveillance has been recommended for CS1 pediatric testicular cancer. However, among high-risk children, more than 50% suffer a relapse and progression during surveillance, and adjuvant chemotherapy needs to be administered....

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Yun-lin, Chen, Zhuang-fei, Bian, Jun, Liang, Hai-tao, Qin, Zi-ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737364/
https://www.ncbi.nlm.nih.gov/pubmed/33317510
http://dx.doi.org/10.1186/s12911-020-01365-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737364/
https://www.ncbi.nlm.nih.gov/pubmed/33317510
http://dx.doi.org/10.1186/s12911-020-01365-x

Ejemplares similares